<sup>153</sup>Sm－EDTMP治疗50例肿瘤性骨痛临床观察

蒯大禹; 李明; 管一晖; 程玮

您当前的位置：

首页 >

文章列表页 >

¹⁵³Sm－EDTMP治疗50例肿瘤性骨痛临床观察

更新时间：2021-04-09

- ¹⁵³Sm－EDTMP治疗50例肿瘤性骨痛临床观察
- Clinical investigation of metastatic bony pain treated by ￣（153）Sm-EDTMP
- 核技术 1995年第11期
- 作者机构：
  
  上海医科大学附属华山医院
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R730.5
- 纸质出版日期：1995-11-01
- 稿件说明：
移动端阅览
[1]蒯大禹,李明,管一晖,程玮.~（153）Sm－EDTMP治疗50例肿瘤性骨痛临床观察[J].核技术,1995(11):697-698.

Clinical investigation of metastatic bony pain treated by ￣（153）Sm-EDTMP[J]. Nuclear techniques, 1995, (11).
[1]蒯大禹,李明,管一晖,程玮.~（153）Sm－EDTMP治疗50例肿瘤性骨痛临床观察[J].核技术,1995(11):697-698. DOI：

Clinical investigation of metastatic bony pain treated by ￣（153）Sm-EDTMP[J]. Nuclear techniques, 1995, (11). DOI：

摘要

５０例不同癌症患者用１５３Ｓｍ－ＥＤＴＭＰ治疗后７６％患者的骨痛有不程度的减轻，骨痛消失率达２０％，骨痛缓解时限１—２个月者为６０％。１０例患者９９ｍＴｃ－ＭＤＰ骨显像患／健侧值与１５３Ｓｍ－ＥＤＴＭＰ相隔１个月两个疗程骨显像患／健侧值自身对照（Ｐ＞０．０５）．表明１５３Ｓｍ－ＥＤＴＭＰ对缓解骨痛、控制临床症状，提高癌症患者的生活质量，作为一种姑息性治疗手段具有明显的临床推广和应用价值．

Abstract

Samarium-153 - ethylendiamine tetramethylene phosphonic acid （EDTMP）

a bone-seeking radiopharmaceutical

was given to treat patients with disseminated bone metastases. A total of fifty patients

26 male and 24 female

44 metastastic and 6 primary bone tumor were treated with a single dose of 1480MBq. Some of them had 153Sm-EDTMP whole-body bone scans 48 hours after 153Sm-EDTMP

and their lesion-to normal ratios of bone were calculated. Overall allevaition of pain with 153Sm-EDTMP was 76% （38150） and 24% of the patients were completely relief from pain. Pain relief sustained from 4 to 8 weeks in 60% of patients.It was suggested that this new therapeutic agent may have a potential benefit for the diagnosis and management of disseminated metastatic bone carciomas.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

¹³¹I治疗分化型甲状腺癌肝转移

快重离子束的应用研究

153Sm－EDTMP治疗50例肿瘤性骨痛临床观察

Clinical investigation of metastatic bony pain treated by ￣（153）Sm-EDTMP

DOI：

摘要

Abstract

关键词

Keywords

references

¹⁵³Sm－EDTMP治疗50例肿瘤性骨痛临床观察